GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Current Deferred Revenue

Alzinova AB (OSTO:ALZ) Current Deferred Revenue : kr0.00 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Alzinova AB's current deferred revenue for the quarter that ended in Sep. 2024 was kr0.00 Mil.

Alzinova AB Current Deferred Revenue Historical Data

The historical data trend for Alzinova AB's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Current Deferred Revenue Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

Alzinova AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alzinova AB Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Alzinova AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Current Deferred Revenue
Comparable Companies
XSAT:CURAS OSTO:ACE OSTO:MVIR OSTO:ONCO OSTO:KDEV XSAT:CESSA OSTO:LIPUM OSTO:XBRANE OSTO:GUARD OSTO:ISOFOL VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
78D:Germany
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Website
https://www.alzinova.com
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB Headlines

No Headlines